The data

Minerva ES® Endometrial Ablation System

Conducted under an FDA approved IDE protocol, this randomized, double-arm, multi-center, controlled, international study utilized rollerball ablation with or without loop resection as the control, and the “statistical superiority is believed to be the first such observation where a nonresectoscopic endometrial ablation device was able to outperform the gold standard rollerball efficacy in an RCT setting.”1

1.,2. Philippe Laberge, MD, et. al., A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results. Journal Minimally Invasive Gynecology

Symphion® Uterine Tissue Removal System

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea.